共 50 条
- [1] Responders Analysis in Patients With Diarrhea-Predominant Irritable Bowel Syndrome IBS-D) Treated With Rifaximin [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S236 - S236
- [3] Rifaximin Repeat Treatment in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Produced No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S761 - S761
- [4] Improvements over Time in Individual Diarrhea-Predominant Irritable Bowel Syndrome Symptoms (IBS-D) with Rifaximin Repeat Treatment [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S240 - S240
- [5] Infection-Related Safety Profile of Rifaximin Repeat Treatment for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S750 - S751
- [7] Analysis of Potential Predictors of Symptom Recurrence in Patients Treated with Rifaximin for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S253 - S253